# Pilot Study of Zoledronic Acid and Interleukin-2 for Refractory Pediatric Neuroblastoma

> **NCT01404702** · PHASE1 · TERMINATED · sponsor: **University of Alabama at Birmingham** · enrollment: 4 (actual)

## Conditions studied

- Neuroblastoma

## Interventions

- **DRUG:** Zoledronic Acid
- **BIOLOGICAL:** Aldesleukin

## Key facts

- **NCT ID:** NCT01404702
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-08
- **Primary completion:** 2014-08
- **Final completion:** 2014-08
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Accrual slower than anticipated
- **Last updated:** 2014-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01404702

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01404702, "Pilot Study of Zoledronic Acid and Interleukin-2 for Refractory Pediatric Neuroblastoma". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01404702. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*